Dr. Sharman explains the impact of using NMR for the quality control and release of drug molecules currently in shortage due to the Coronavirus pandemic.
We are living through a public health crisis the likes of which has not been seen for generations. But we go into this crisis with one key advantage compared to previous generations – our scientific knowledge and capabilities are a major weapon against the virus, and we find ourselves in a race against time to develop effective therapies and preventative treatments. NMR is a key technique that forms a part of the backbone of analytical chemistry which so underpins much of drug discovery, development and manufacturing.
During this webinar hosted by Bruker, Dr. Gary Sharman stresses the importance of NMR in this process, with particular reference to COVID-19. He focuses primarily on the impact of using NMR for the quality control and release of existing drug molecules which are in shortage for one reason or another due to the pandemic, and on the solutions which can assist in this process. This presentation will be of particular interest to both spectroscopists and non-NMR experts alike.
Senior Scientific Director
Additional Content From Bruker BioSpin
Stimulating and Recording Neuronal Activity During Traditional fMRI, and the Benefits When Doing This at “Zero” Echo Time
Experts discuss electrical and optical-based techniques capable of stimulating and recording neuronal activity during fMRI, share examples using these tools to study neurovascular coupling, and introduce a method to acquire fMRI data at zero echo time and discuss the advantages over traditional fMRI technique.
Dr. Raanan Carmieli discusses the use of electron paramagnetic resonance (EPR) as a powerful technique for the study of transition metals, organic radical ions and transient radical-pairs in photoexcited systems.
Dr. Marty Pagel introduces the CEST MRI technique, demonstrates a basic experiment, and explains why measuring protein, acid, and metabolite content can be so beneficial in applications of brain ischemia and cancer.
A Comprehensive How-To Demonstration of Higher Throughput Excitation-Contraction Coupling Investigations
Join Michiel Helmes and Diederik Kuster as they demonstrate best practices and new techniques in high-content, higher throughput investigations of excitation-contraction coupling in isolated cardiomyocytes.
OBESITY SERIES 2020: Dr. Ania Jastreboff discusses the current use of anti-obesity pharmacotherapy, mechanisms involved, and agents in various stages of development with considerations for next steps.
Solid-state NMR Spectroscopy in Pharmaceutical Sciences from Drug Delivery to Formulation Development
Join Dr. Yongchao Su for an overview of the versatile roles of ssNMR in pharmaceutical development, providing a structural basis for the design of drug substances and products.